The power of mitochondria in Parkinson’s disease treatment
The Boston-based biotech Vincere Biosciences has a mission: to improve the quality of mitochondria in our cells. The company was spun off from AI drug discovery company NeuroInitiative, in 2018, after its platform determined that modulation to repair mitochondrial function \”may slow down or stop the progress of Parkinson’s and other age-related diseases.\”
Vincere, in addition to receiving seed funding, has also received grants from both the National Institutes of Health (NIH) and Michael J. Fox Foundation. The company is currently preparing for its Series A funding round, which will take place at the beginning of 2022.
Longevity. The role of mitochondria in extending life expectancy is a hot technology topic. These tiny organs, often referred to by scientists as \”the powerhouse of the cellular\”, play an important role in providing energy for growth and repair. As we age our mitochondria start to lose function. This decline is associated with a variety of age-related illnesses. Spring Behrouz, co-founder of Vincere and its CEO, was interviewed to learn how the company hopes to harness the power of these tiny but powerful biological players.
Source:
